[1] SULLIVAN M M,SAGE E H.Hevin/SC1,a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family[J].International Journal of Biochemistry & Cell Biology,2004,36(6):991-996. [2] XIANG Y,QIU Q,JIANG M,et al.SPARCL1 suppresses metastasis in prostate cancer[J].Molecular Oncology,2013,7(6):1019-1030. [3] MEISSBURGER B,PERDIKARRI A,MOEST H,et al.Regulation of adipogenesis by paracrine factors from adipose stromal-vascular fraction——A link to fat depot-specific differences[J].Biochimica et Biophysica Acta,2016,1861(9):1121-1131. [4] CLAESKENS A,ONGENAE N,NEEFS J M,et al.Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation[J].British Journal of Cancer,2000,82(6):1123-1130. [5] HUANG H B,YANG S B,SHEN L J,et al.A prospective study on serum secreted protein acidic and rich in cysteine-like 1 as a prognostic marker for severe traumatic brain injury[J].Clinica Chimica Acta,2019,491(4):19-23. [6] CHAOYONG S,YUAN Y,HUIJIAO C,et al.Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors[J].BMC Gastroenterology,2018,18(1):105-130. [7] HU H,CAI W,ZHENG S,et al.SPARCL1,a novel prognostic predictive factor for GI malignancies:A meta-analysis[J].Cellular Physiology and Biochemistry,2017,44(4):1485-1496. [8] EDDIGHI S,VARMA V R,AN Y,et al.SPARCL1 accelerates symptom onset in Alzheimer's disease and influences brain structure and function during aging[J].Journal of Alzheimers Disease,2018,61(1):401-414. [9] 孙丽敏,李佳蓉,贾超,等.小尾寒羊为母本二元及三元肉羊杂交模式杂种优势比较分析[J].中国畜牧杂志,2017,53(3),45-48. SUN L M,LI J R,JIA C,et al.Comparative analysis of feterosis of two-way and three-way cross modes mutton[J].Chinese Journal of Animal Science,2017,53(3):45-48.(in Chinese) [10] LAU C P,POON R T,CHEUNG S T,et al.SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma[J].Journal of Pathology,2006,210(4):459-468. [11] OTTO T C,LANE M D.Adipose development:From stem cell to adipocyte[J].Critical Reviews in Biochemistry & Molecular Biology,2005,40(4):229-242. [12] FERNYHOUGH M E,HAUSMAN G J,GUAN L L,et al.Mature adipocytes may be a source of stem cells for tissue engineering[J].Biochemical & Biophysical Research Communications,2008,368(3):455-457. [13] HIRATA K,WADA K,MURATA Y,et al.Critical role of leukotriene B4 receptor signaling in mouse 3T3-L1 preadipocyte differentiation[J].Lipids in Health & Disease,2013,12(1):122-128. [14] FRAMSON P E,SAGE E H.SPARC and tumor growth:Where the seed meets the soil[J].Journal of Cellular Biochemistry,2004,92(4):679-690. [15] JONES E V,BOUVIER D S.Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease[J].Neural Plasticity,2014,2014:321209. [16] HAMBROCK H O,KAUFMANN B,MULLER S,et al.Structural characterization of TSC-36/Flik:Analysis of two charge isoforms[J].Journal of Biological Chemistry,2004,279(12):11727-11735. [17] MAURER P,HOHENADL C,HOHENESTER E,et al.The C-terminal portion of BM-40(SPARC/Osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen Ⅳ[J].Journal of Molecular Biology,1995,253(2):347-357. [18] SASAKI T,MIOSGE N,TIMPL R.Immunochemical and tissue analysis of protease generated neoepitopes of BM-40(osteonectin,SPARC) which are correlated to a higher affinity binding to collagens[J].Matrix Biology,1999,18(5):499-508. [19] ISLER S G,SCHENK S,BENDIK I,et al.Genomic organization and chromosomal mapping of SPARC-like 1,a gene down regulated in cancers[J].International Journal of Oncology, 2001,18(3):521-526. [20] NASCHBERGER E,LIEBL A,SCHELLERER V S,et al.Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma[J].Journal of Clinical Investigation,2016,126(11):4187-4204. [21] LI P,QIAN J,YU G,et al.Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer[J].Journal of Surgical Oncology,2012,105(1):31-37. [22] ESPOSITO I,KAYED H,KELEG S,et al.Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer[J].Neoplasia,2007,9(1):8-17. [23] ANDREI T,DAVIDE M,ANTONIO G N,et al.Sparc-like protein 1 is a new marker of human glioma progression[J].Journal of Proteome Research,2012,11(10):5011-5021. [24] FAGERBERG L,HALLSTROM B M,OKSVOLD P,et al.Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics[J].Molecular & Cellular Proteomics,2014,13(2):397-406. |